TIL Therapy Amplifies the Immune System’s Attack on Melanoma
The recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.
The recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.
The FDA has granted accelerated approval to lifileucel, a new type of cell therapy, for the treatment of melanoma. The U.S. Food and Drug Administration (FDA) has granted accelerated approval to lifileucel (Amtagvi) for...
The FDA approved nivolumab for some patients with melanoma whose tumor was completely removed through surgery and has not spread. The U.S. Food and Drug Administration (FDA) has approved the checkpoint inhibitor nivolumab (Opdivo)...
Lorazepam used to relieve stress may cause inflammation that promotes tumor growth and shortens progression-free survival, study says. A medication commonly used to ease the stress caused by cancer diagnosis and treatment may be...
The FDA approved a kit that allows for liver-directed delivery of the chemotherapy melphalan to treat metastatic liver disease from uveal melanoma. The U.S. Food and Drug Administration (FDA) has approved a kit for...
Adoptive T-cell therapy shows promise in treating metastatic melanoma.
Study finds mRNA vaccine can help prevent cancer recurrence in advanced melanoma patients.
Immunotherapy before surgery is proving to be an effective treatment against melanoma.
Researchers find that when treating metastatic melanoma, timing is everything.
The FDA approved nivolumab and relatlimab-rmbw (Opdualag) for some patients with advanced melanoma The U.S. Food and Drug Administration (FDA) has approved a combination of the checkpoint inhibitors nivolumab and relatlimab-rmbw (Opdualag) for...